newsfilter
← Latest News
PR Newswire·

Invitation to presentation of BioArctic's second quarter report for April - June 2026 on August 26 at 9:30 a.m. CEST

  • BioArctic AB (publ) will publish its second quarter report for April-June 2026 on August 26, 2026, at 8:00 a.m. CEST.
  • A webcast for investors, analysts, & media will occur on August 26 at 9:30 a.m. CEST to present results & allow for Q&A.
  • CEO Gunilla Osswald & CFO Anders Martin-Löf will lead the presentation alongside colleagues.
  • Written questions for the webcast can be submitted via https://bioarctic.events.inderes.com/q2-report-2026/register.
  • Verbal questions can be addressed via teleconference using https://events.inderes.com/bioarctic/q2-report-2026/dial-in after registration.
  • The webcast will be available on demand at https://www.bioarctic.com/en/investors/financial-reports-and-presentations/ following the event.
  • BioArctic is a Swedish biopharma company focusing on treatments for neurodegenerative diseases, including Leqembi® for Alzheimer's disease developed with Eisai.
  • The company's B shares (BIOA B) are listed on Nasdaq Stockholm Large Cap.
  • Media inquiries can be directed to Oskar Bosson or Jenny Ljunggren via the provided contact details.